14.60

0.41% 0.11

Benitec Biopharma Inc (BNTC)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$14.49

Offen:

$14.89

24-Stunden-Volumen:

26,425

Relative Volume:

0.57

Marktkapitalisierung:

$346.85M

Einnahmen:

$59,000

Nettoeinkommen (Verlust:

$-21.81M

KGV:

-1.3331

EPS:

-10.9518

Netto-Cashflow:

$-18.07M

1W Leistung:

+12.01%

1M Leistung:

+50.00%

6M Leistung:

+78.53%

1J Leistung:

+180.35%

1-Tages-Spanne:

$14.14

$15.01

1-Wochen-Bereich:

$11.99

$15.01

52-Wochen-Spanne:

$4.75

$15.01

Benitec Biopharma Inc Stock (BNTC) Company Profile

Firmenname

Benitec Biopharma Inc

Sektor

Healthcare (1172)

Branche

Biotechnology (680)

Telefon

(510) 780-0819

Adresse

3940 TRUST WAY, HAYWARD, CA

Mitarbeiter

Twitter

@BenitecLtd

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

BNTC's Discussions on Twitter

Vergleichen Sie BNTC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BNTC Benitec Biopharma Inc	14.50	346.85M	59,000	-21.81M	-18.07M	-10.95
VRTX Vertex Pharmaceuticals Inc	500.79	130.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	681.60	75.53B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	580.01	35.07B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	241.23	31.72B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	252.89	26.76B	3.32B	-860.46M	-1.04B	-8.32

Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-12-16	Eingeleitet	H.C. Wainwright	Buy
2024-12-13	Eingeleitet	Robert W. Baird	Outperform
2024-10-16	Eingeleitet	Oppenheimer	Outperform
2024-09-12	Eingeleitet	Guggenheim	Buy
2024-07-22	Eingeleitet	Leerink Partners	Outperform
2024-06-13	Eingeleitet	Piper Sandler	Overweight
2020-10-05	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2020-04-20	Eingeleitet	Ladenburg Thalmann	Buy
2016-02-26	Herabstufung	Maxim Group	Buy → Hold
2015-12-31	Bestätigt	Maxim Group	Buy
2015-09-16	Bestätigt	Maxim Group	Buy

Alle ansehen

Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten

08:02 AM

BenitecAnother Biopharma Rocket - Barchart

08:02 AM

Mar 12, 2025

Benitec Biopharma (NASDAQ:BNTC) Shares Cross Above 50-Day Moving Average – Here’s Why - Defense World

Mar 12, 2025

Benitec BiopharmaGetting To The Roots Of Oculopharyngeal Muscular Dystrophy - RTTNews

Mar 12, 2025

Mar 11, 2025

Benitec Biopharma stock soars to 52-week high of $13.32 By Investing.com - Investing.com Australia

Mar 11, 2025

Benitec Biopharma stock soars to 52-week high of $13.32 - Investing.com India

Mar 11, 2025

Mar 10, 2025

Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Mar 10, 2025

Mar 04, 2025

How to Take Advantage of moves in (BNTC) - Stock Traders Daily

Mar 04, 2025

Feb 27, 2025

Antisense & RNAi Therapeutics Market to Set Remarkable Growth - openPR

Feb 27, 2025

Feb 26, 2025

Benitec Biopharma to Participate in Upcoming Conferences in March - GlobeNewswire

Feb 26, 2025

Reviewing NexImmune (NASDAQ:NEXI) & Benitec Biopharma (NASDAQ:BNTC) - Defense World

Feb 26, 2025

Feb 25, 2025

Benitec Biopharma's SWOT analysis: gene therapy stock shows promise amid trials By Investing.com - Investing.com South Africa

Feb 25, 2025

Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise amid trials - Investing.com India

Feb 25, 2025

Benitec Biopharma's SWOT analysis: gene therapy stock shows promise amid trials - Investing.com

Feb 25, 2025

Feb 23, 2025

Wall Street Analysts Predict a 127.26% Upside in Benitec Biopharma (BNTC): Here's What You Should Know - MSN

Feb 23, 2025

HC Wainwright Reiterates “Buy” Rating for Benitec Biopharma (NASDAQ:BNTC) - Defense World

Feb 23, 2025

Feb 21, 2025

(BNTC) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Feb 21, 2025

H.C. Wainwright maintains $28 target on Benitec BioPharma stock By Investing.com - Investing.com UK

Feb 21, 2025

Feb 20, 2025

Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

Feb 20, 2025

Feb 19, 2025

Citizens JMP maintains Benitec stock with $18 target By Investing.com - Investing.com Australia

Feb 19, 2025

Citizens JMP maintains Benitec stock with $18 target - Investing.com India

Feb 19, 2025

Feb 18, 2025

Benitec Biopharma (NASDAQ:BNTC) Announces Earnings Results, Beats Estimates By $0.19 EPS - MarketBeat

Feb 18, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Rating of “Buy” from Analysts - Defense World

Feb 18, 2025

Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Feb 18, 2025

Feb 17, 2025

Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat

Feb 17, 2025

Feb 16, 2025

Benitec Biopharma Inc. Announces Q4 2024 Financial Results and Operational Update - Defense World

Feb 16, 2025

Feb 15, 2025

Benitec Biopharma Announces Acceptance of Late- Breaking - GlobeNewswire

Feb 15, 2025

Feb 14, 2025

Benitec presents new gene therapy data at MD conference By Investing.com - Investing.com Canada

Feb 14, 2025

Benitec presents new gene therapy data at MD conference - Investing.com India

Feb 14, 2025

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update - TradingView

Feb 14, 2025

Benitec Biopharma Inc. Announces Late-Breaking Presentation on BB-301 Phase 1b/2a Clinical Study for Oculopharyngeal Muscular Dystrophy at 2025 MDA Conference - Nasdaq

Feb 14, 2025

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference - The Manila Times

Feb 14, 2025